Search Results 1311-1320 of 15870 for Residual

  1. Rectal cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.

  2. Study to Better Understand the Development of Irritable Bowel Disease (IBD) and Related Diseases as a Step Toward Improving Disease Outcomes. - Mayo Clinic

    The purpose of this study is to better understand disease development of Irritiable Bowel Disease (IBD) and related diseases as a step to improving disease ...

  3. Rectal cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.

  4. Rectal cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.

  5. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  6. Rectal cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.

  7. Rectal cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.

  8. Rectal cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.

  9. A Study Of PAFOLACIANINE INJECTION In Children And Adolescents - Mayo Clinic

    About this study. The purpose of this study is to obtain PK data on OTL38, following a single-dose injection of 0.025 mg/kg, in a pediatric population aged ...

  10. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors - Mayo Clinic

    * History of another malignancy within 3 years before the first dose of study intervention, or any evidence of residual disease from a previously diagnosed ...